Inborn Errors of Metabolism (IEMs) are a diverse group of monogenic genetic disorders caused by inherited defects in specific enzymes, transport proteins, or cofactors within cellular biochemical pathways. These enzymatic bottlenecks trigger either toxic upstream substrate accumulation (e.g., phenylalanine neurotoxicity in PKU) or critical downstream energy deficiency (e.g., hypoketotic hypoglycemia in MCAD deficiency). Modern universal Newborn Screening (NBS) via Tandem Mass Spectrometry (MS/MS) enables early detection and dietary intervention before irreversible organ damage occurs.
First conceptualized in 1908 by British physician Sir Archibald Garrod (who coined the term while studying alkaptonuria), Inborn Errors of Metabolism (IEMs) represent the clinical intersection of genetics and biochemistry.
While individual metabolic disorders are rare, collectively they affect 1 in every 1,000 to 2,500 newborns, representing a major category of pediatric and adult genetic medicine.
When a single enzyme in an amino acid, fatty acid, or carbohydrate pathway fails, the metabolic highway gridlocks - causing toxic intermediates to spill into the bloodstream while vital downstream cellular fuel sources run dry.
What are the 5 major biochemical classifications of IEMs, how does tandem mass spectrometry power universal newborn screening, and what are the clinical warning signs of metabolic decompensation?
The Pathophysiological Mechanism of an Enzymatic Block#
In every metabolic pathway, substrate $A$ is converted to intermediate $B$, which is converted to vital product $C$ by specific enzymes:
[Normal Pathway]: Substrate A ──(Enzyme 1)──► Intermediate B ──(Enzyme 2)──► Essential Product C
│
[GENETIC LOSS-OF-FUNCTION MUTATION]
│
▼
[IEM Blocked Pathway]: Substrate A ──(Enzyme 1)──► [MASSIVE ACCUMULATION OF B] ──(X)──► [DEFICIENCY OF C]
│
▼
[Toxic By-Product Spillover]
(e.g., Phenylpyruvate, Ammonia, Organic Acids)
- Toxic Substrate Accumulation: Accumulating upstream metabolites can directly poison the central nervous system, liver, or kidneys (e.g., phenylalanine in PKU causing irreversible cognitive impairment).
- End-Product Deficiency: Failure to generate downstream products halts cellular respiration (e.g., inability to produce glucose-6-phosphate during fasting in Glycogen Storage Disease Type I).
- Alternative Pathological Routing: Shunting excess substrate into secondary pathways creates toxic organic acids.
The 5 Major Biochemical Classifications of IEMs#
| Category | Representative Disorder | Defective Enzyme / Gene | Pathophysiological Manifestation |
|---|---|---|---|
| 1. Amino Acid Disorders | Phenylketonuria (PKU) | Phenylalanine Hydroxylase (PAH) | Toxic build-up of phenylalanine; treated with lifelong dietary phenylalanine restriction and BH4 cofactor. |
| Maple Syrup Urine Disease (MSUD) | Branched-Chain $\alpha$-Ketoacid Dehydrogenase (BCKAD) | Toxic accumulation of leucine, isoleucine, and valine; sweet-smelling urine, rapid cerebral edema. | |
| 2. Organic Acidemias | Methylmalonic Acidemia (MMA) | Methylmalonyl-CoA Mutase (MUT) | Severe anion-gap metabolic ketoacidosis, hyperammonemia, and developmental regression. |
| 3. Fatty Acid Oxidation Disorders (FAODs) | Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency | Medium-Chain Acyl-CoA Dehydrogenase (ACADM) | Inability to oxidize medium-chain fats during fasting; causes sudden hypoketotic hypoglycemia and lethargy. |
| 4. Carbohydrate & Glycogen Disorders | Galactosemia | Galactose-1-Phosphate Uridylyltransferase (GALT) | Inability to process milk galactose; jaundice, cataracts, and liver failure upon dairy exposure. |
| GSD Type I (von Gierke) | Glucose-6-Phosphatase (G6PC) | Inability to release free glucose from liver glycogen; severe fasting hypoglycemia and lactic acidosis. | |
| 5. Urea Cycle Disorders (UCDs) | Ornithine Transcarbamylase (OTC) Deficiency | Ornithine Transcarbamylase (OTC) | Failure of the hepatic urea cycle; severe hyperammonemia causing acute encephalopathy. |
Universal Newborn Screening (NBS) & Tandem Mass Spectrometry#
Before the advent of modern mass spectrometry, infants with IEMs often suffered catastrophic brain injury before a diagnosis was reached.
[Infant Heel-Prick at 24 to 48 Hours of Life]
│
▼
[Dried Blood Spot on Whatman Filter Paper (Guthrie Card)]
│
▼
[Tandem Mass Spectrometry (MS/MS) Analysis]
- Simultaneously quantifies dozens of Amino Acids & Acylcarnitines in 2 minutes.
│
┌────────────┴────────────┐
▼ ▼
[Elevated Phenylalanine ──► PKU] [Elevated C8 Acylcarnitine ──► MCAD Deficiency]
- The Recommended Uniform Screening Panel (RUSP): Screens newborns for over 35 core inborn errors of metabolism immediately after birth.
- Acylcarnitine Profiling: Tandem MS measures specific acylcarnitine species (e.g., Octanoylcarnitine / C8 for MCAD; Propionylcarnitine / C3 for methylmalonic acidemia) to pinpoint the exact enzyme deficiency in minutes.
The Clinical Emergency Workup for Suspected Metabolic Crisis#
When an infant or adult presents with acute lethargy, vomiting, or encephalopathy of unknown origin, emergency physicians order the Foundational Metabolic Crisis Lab Panel:
- Blood Ammonia ($NH_3$): Rapidly identifies Urea Cycle Disorders (UCDs) and organic acidemias.
- Blood Glucose & Urine Ketones: Distinguishes ketotic hypoglycemia from hypoketotic hypoglycemia (the hallmark of Fatty Acid Oxidation Disorders).
- Arterial Blood Gas (ABG) & Electrolytes: Calculates the Serum Anion Gap to identify severe metabolic acidosis.
- Plasma Amino Acids & Urine Organic Acids: Comprehensive chromatographic profiling for definitive biochemical diagnosis.
Patients with fatty acid oxidation defects rely entirely on glucose. If they fast for more than 10 to 12 hours (such as during a gastrointestinal illness), glycogen stores empty, and because they cannot burn fat, they suffer sudden life-threatening hypoglycemia without protective ketones.
To explore how the liver and kidney filter metabolic waste products, read What Is a Comprehensive Metabolic Panel? The 14 Biomarkers Guide.
Track Your Health & Diagnostic Lab Records with Meridian#
Monitoring your laboratory blood biomarkers over time gives you objective validation that your diet, exercise, and lifestyle habits are keeping your metabolic health and glucose tolerance in optimal ranges.
Meridian is an offline personal health vault for iPhone designed to give you complete ownership of your medical diagnostic data.
- Instant Lab Report Extraction: Take a photo or upload a PDF of your Comprehensive Metabolic Panel, Plasma Amino Acids, Lipid Panel, and Genetics/Newborn reports from Quest, Labcorp, or your clinic. Meridian extracts all biomarkers on-device using Apple VisionKit.
- Longitudinal Metabolic Tracking: Keep all your complex lab panels, genetic summaries, and metabolic profiles organized in one secure dashboard with complete privacy.
- 100% On-Device & Private: Protected by hardware AES-256 encryption and FaceID. Zero cloud servers. Zero data tracking.
Take control of your biological health and medical privacy today. Download Meridian on the App Store and keep your diagnostic records organized, private, and secure.